Sorry, this entry is only available in Ukrainian and Russian.
Rommelag – розширене керування життєвим циклом продукту
Вас может заинтересовать:
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
WEB only
On June 26, 2023, the Japanese Pharmaceutical Company Shionogi & Co., Ltd and the Medicines Patent Pool (MPP), a United Nations-backed international public health organization, have announced the signature of…
